GI - Colorectal and Non-Colorectal

Featuring:
Dr. Stephanie Snow

GI - Colorectal and Non-Colorectal

Featuring:
Dr. Sharlene Gill

CheckMate 649, ATTRACTION-4, KEYNOTE-062, KEYNOTE-590 and CheckMate 577

Gastroesophageal Cancer
Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

KEYNOTE-177 and PRODIGE 13

GI Colorectal
Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

KEYNOTE-590 Study

Featuring:
Dr. Ken Kato

CheckMate 577 Study

Featuring:
Dr. Ronan Kelly

CheckMate 649 study

Featuring:
Dr. Markus Moehler

HAIC with FOLFOX vs. TACE for unresectable HCC

Featuring:
Dr. Ming Shi

The Canadian Cancer Trials Group PA.7 Trial

Featuring:
Dr. Daniel Renouf

KEYNOTE-177 Study

Featuring:
Dr. Thierry André

ESMO 2020 Virtual Data Watch - GI

Understanding the Approach to Managing Skin Toxicities Associated with Managing mCRC

Featuring:
Dr. Mario Lacouture
Chair:
Dr. Nathan Lamond

Colorectal GI Cancer

Featuring:
Dr. Jonathan Loree

Non-Colorectal GI Cancer

Featuring:
Dr. Patricia Tang

Non-Colorectal GI Cancer

Featuring:
Dr. Frédéric Lemay

Colorectal GI Cancer

Featuring:
Dr. Petr Kavan

Does treatment sequencing matter in metastatic colorectal cancer?

Featuring:
Dr. Julien Taieb
Chair:
Dr. Scott Berry

Colorectal GI Cancers

Featuring:
Dr. Sharlene Gill

Non-Colorectal GI Cancers

Featuring:
Dr. Grainne O'kane

PETRARCA, NRG/RTOG 1010 & RAMSES/FLOT7

Periporative/Neoadjuvant Gastroesophageal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

SWOG S1505 & ESPAC 5F

Pancreatic Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

DESTINY-Gastric01

Metastatic Gastroesophageal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

RAPIDO, UNICANCER PRODIGE 23 & OPRA

Rectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

KEYNOTE-177 & PANDA

Metastatic Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

IDEA, CALGB/SWOG 80702 & JCOG0603

Adjuvant Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

MEDETREME Trial

Featuring:
Dr. Francois Ghiringhelli

ASCO20 Virtual Data Watch: GI Cancers

Esophago-Gastric Cancer

Featuring:
Dr. Elena Elimova

Pancreatic Cancer

Featuring:
Dr. Yoo-Joung Ko

Hepatobiliary Cancer

Featuring:
Dr. Mark Doherty

Colorectal Cancer

Featuring:
Dr. Scott Berry

Case-Based Presentation in GI Cancers

Featuring:
Dr. Suneil Khanna

GI Faculty Panel Discussion and Q&A

Featuring:
Dr. Scott Berry
Dr. Mark Doherty
Dr. Yoo-Joung Ko
Dr. Suneil Khanna

GI Colorectal and Non-Colorectal

Featuring:
Dr. Sharlene Gill

Sequoia Trial

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

GemCis +/- Veliparib in BRCA mutated Pancreatic CA

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

KEYNOTE-158 Study

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

JCOG 1007 Study (IPACS)

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

Javelin Gastric 100 Trial

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

Beacon CRC Trial

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

Expel Trial

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

Halo 109-301 Trial

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

Patient Reported Outcomes From Imbrave 150

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

GI Colorectal and Non-Colorectal Cancer Update

Featuring:
Dr. Mike Vickers

Breakfast Symposium: HCC

Featuring:
Dr. Yoo-Joung Ko

Circulating Tumour DNA Trials

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

ANGEL study

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

KEYNOTE-062

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

BEACON Trial

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

ClarIDHy Trial

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

ATTRACTION-3 Study

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

CheckMate 459 Trial

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

Delays to Systemic therapy and impact to therapy

Featuring:
Dr. Brandon Meyers

TKI toxicity and dose modifications

Featuring:
Dr. Vincent Tam

Treatment Paradigm

Featuring:
Dr. Peter Metrakos

ClarIDHy Study

Featuring:
Dr. Ghassan Abou-Alfa

KEYNOTE-062 Trial

Featuring:
Dr. Kohei Shitara

Colorectal GI Cancer

Featuring:
Dr. Hagen Kennecke

Non-Colorectal GI Cancer

Featuring:
Dr. Sharlene Gill

Non-Colorectal GI Cancer

Featuring:
Dr. Christine Brezden-Masley

Colorectal GI Cancer

Featuring:
Dr. Mark Doherty

Colorectal and Non Colorectal GI Cancer

Featuring:
Dr. Benoit Samson

IDEA Study (High Risk Stage 2 Patients)

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Foxtrot Trial

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

ABC-06

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Phase 3 Trial of 1st Line Chemo vs Pembrolizumab vs Chemo + Pembrolizumab for Metastatic Gastric CA

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Phase 3 Trial of 2nd Line Pembrolizumab vs Placebo for HCC

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Polo Trial

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Apact Trial

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Trials of Oxaliplatin-based Therapy 3 vs. 6 months in Colorectal Cancer

Featuring:
Dr. Tim Iveson

Namodenoson in Patients with Child-Pugh B HCC

Featuring:
Dr. Salomon Stemmer

NRG-GI002 Study

Featuring:
Dr. Thomas George

Foxtrot Study

Featuring:
Dr. Dion Morton

Esophago-Gastro Cancer

Featuring:
Dr. Christine Brezden-Masley

Keynote Lecture: Newer Advances in the Treatment of Late Stage MCRC

Featuring:
Dr. Michael Morse

Pancreatic Cancer

Featuring:
Dr. Yoo-Joung Ko

Case-Based Presentations In GI Cancers

Featuring:
Dr. Suneil Khanna

Hepatobiliary Cancer

Featuring:
Dr. Mark Doherty 

Colorectal Cancer

Featuring:
Dr. Ron Burkes

GI Colorectal

Featuring:
Dr. Patricia Tang

GI Non-Colorectal

Featuring:
Dr. Sharlene Gill

Best of Oncology East 2018 - Non-Colorectal GI Cancer

Featuring:
Dr. Suneil Khanna

Best of Oncology East 2018 - Colorectal GI Cancer

Featuring:
Dr. Scott Berry

Pain Management & Holistic Care

Featuring:
Dr. Martin Chasen
Dr. Scott Berry

Steatorrhea, Pancreatic Enzyme Insufficiency, & Diagnosing Diabetes

Featuring:
Dr. Michael Sawyer
Jessica Kasnik

Comorbidities and Concomitant Use of Medications

Featuring:
Dr. Tim Asmis
Lisa Rambout

Diabetic Patient Considerations and Neuropathy Management

Featuring:
Dr. Tim Asmis
Lisa Rambout

Atezo + Bev in HCC

Featuring:
Dr Michael Pishvaian

TAGs Trial

Featuring:
Dr. Hendrik Tobias Arkenau

MODUL Study - Updates in Metastatic Colorectal Cancer

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

TRIBE 2 Study - Updates in Unresectable Metastatic Colorectal Cancer

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

TAGS Study - Updates in Metastatic Gastric Cancer

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

NIVO + IPI 1L - Updates in Metastatic Colorectal Cancer

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

InterAACT Study - Updates in Anal Cancer

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

Updates in Biliary Tract Cancer 

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

KEYNOTE-181 study

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

The COMPASS Trial

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

Treatment BRAF V600E–mutated biliary tract cancer: a cohort of the ROAR basket trial

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

CCTG CO.26 trial

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

The COLOPEC Trial

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

NIVO + IPI 1L IN MSI-H/DMMR MCRC

Featuring:
Dr. Heinz-Josef Lenz

Best of ASCO Vancouver 2018 - Colorectal GI Cancer

Featuring:
Dr. Sharlene Gill

Best of ASCO Vancouver 2018 - Non-Colorectal GI Cancer

Featuring:
Dr. Vincent Tam

Best of ASCO Toronto 2018 - Non-Colorectal GI Cancer

Featuring:
Dr. Elena Elimova

Canadian Achievements in Cancer Research, PRODIGE 24

Featuring:
Dr. Jim Biagi

Best of ASCO Toronto 2018 - Colorectal GI Cancer

Featuring:
Dr. Scott Berry

Best of ASCO Montreal 2018 - GI Cancers (Non-Colorectal and Colorectal)

Featuring:
Dr. Frederic Lemay

PRODIGE 24/PA.6 TRIAL - Updates in Pancreatic Cancer

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

PRODIGE 7 - Updates in Colorectal Cancer & Isolated Peritoneal Metastases

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

ECOG 7208 Study - Updates in Advanced Colorectal Cancer

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

ADORE Trial - Updates in Resected Rectal Cancer

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

REACH2 STUDY - Updates in Hepatocelluar Carcinoma

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

KEYNOTE-061 trial

Featuring:
Dr. Charles Fuchs

PRODIGE 24/CCTG PA.6 Trial

Featuring:
Dr. Jim Biagi

Updates in Pancreatic Neuroendocrine Tumours

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Best of GUGI 2018 - Pancreatic Cancer

Featuring:
Dr. Yoo-Joung Ko

Best of GUGI 2018 - Esophago-Gastro Cancer

Featuring:
Dr. Elena Elimova

Best of GUGI 2018 - Hepatobiliary Cancer

Featuring:
Dr. Mark Doherty

Best of GUGI 2018 - Colorectal Cancer

Featuring:
Dr. Rachel Goodwin

Best of Oncology East 2017 - Colorectal GI Cancer

Featuring:
Dr. Ronald Burkes

Best of Oncology East 2017 - Non-Colorectal GI Cancer

Featuring:
Dr. Elena Elimova

Debate: Should Patients with Resected Stage 3 Colon Cancer Receive 3 or 6 Months Oxaliplatin-Based Chemo? -3 months

Featuring:
Dr. Jeff Myers

Debate: Should Patients with Resected Stage 3 Colon Cancer Receive 3 or 6 Months Oxaliplatin-Based Chemo? -6 months

Featuring:
Dr. Robert El-Maraghi

Best of Oncology West 2018 - Colorectal GI Cancer

Featuring:
Dr. Sharlene Gill

Best of Oncology West 2018 - Non-Colorectal GI Cancer

Featuring:
Dr. Daniel Renouf

RAINFALL Trial: Chemotherapy With or Without Ramicirumab for Untreated Metastatic Gastric Cancer

Featuring: Dr. Scott Berry
Dr. Daniel Renouf
Dr. Sharlene Gill

FUGA-BT Trial: Gemcitabine plus S-1 vs Gemcitabine plus Cisplatin in Advanced Biliary Tract Cancer

Featuring:
Dr. Scott Berry
Dr. Daniel Renouf
Dr. Sharlene Gill

Celestial Trial: Cabozantinib vs Placebo in Sorafenib Resistant Hepatocellular Carcinoma

Featuring:
Dr. Scott Berry
Dr. Daniel Renouf
Dr. Sharlene Gill

Update on Checkmate 142

Featuring:
Dr. Scott Berry
Dr. Daniel Renouf
Dr. Sharlene Gill

Video 1: Advanced in Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Video 2: Advanced in Non-Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

JACOB Study: Pertuzumab in the 1st Line Treatment of HER2+ Metastatic Gastric Cancer

Featuring:
Dr. Scott Berry

PRODIGE 18 Study

Featuring:
Dr. Jaafar Bennouna

KEYNOTE-028 Study

Featuring:
Dr. Janice Mehnert

VOLFI Trial of the AIO(AIO-KRK0109)

Featuring:
Dr. Michael Geissler

German AIO KRK0110 (ML22011) Study

Featuring:
Dr. Dominik Modest

Updates in Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Hagen Kennecke
Dr. Marc Peeters

Updates in Non-Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Hagen Kennecke
Dr. Marc Peeters

Case 1: Adjuvant Therapy

Featuring:
Dr. Scott Berry
Dr. Ramesh Ramanathan
Dr. Robert El-Maraghi

Case 2: Metastatic Disease - First Line Options (Overview)

Featuring:
Dr. Scott Berry
Dr. Ramesh Ramanathan
Dr. Robert El-Maraghi

Case 3: Metastatic Disease - First Line Options (Older Patients and Patients with Poorer PS)

Featuring:
Dr. Scott Berry
Dr. Ramesh Ramanathan
Dr. Robert El-Maraghi

Case 4: Treating Metastatic Disease with Gemcitabine and Nab-Paclitaxel (Hyperbilirubinemia and A/E Management)

Featuring: Dr. Scott Berry
Dr. Ramesh Ramanathan
Dr. Robert El-Maraghi

Alliance Trial: American Cancer Society Nutrition & Physical Activity Guidelines

Featuring:
Dr. Erin Van Blarigan

SCOT Study: Final DFS Results

Featuring:
Dr. Timothy Iveson

SIRveNIB Trial

Featuring:
Dr. Pierce Chow

CALGB / SWOG 80405 (ALLIANCE) - Association of Mutations With OS

Featuring:
Dr. Federico Innocenti

METIVHCC Trial

Featuring:
Dr. Lorenza Rimassa

FLOT4-AIO Trial

Featuring:
Dr. Scott Berry

CALGB / SWOG 80405 (Alliance) - Prognostic Value of Primary Tumor Location

Featuring:
Alan P. Venook

IDEA Trial Summary

Featuring:
Dr. Ron Burkes

SWOG 21406 Trial 2

Featuring:
Dr. Scott Kopetz

Breakfast Symposium

Gastric Cancer in 2016 - The important Role of Nutrition

Featuring:
Dr. Christine Brezden-Masley
Denise Gabrielson

Best of GUGI 2017 - Pancreatic Cancer

Featuring:
Dr. Yooj Ko

Best of GUGI 2017 - Esophago-Gastro Cancer

Featuring:
Dr. Christine Brezden-Masley

Best of GUGI 2017 - Colon Cancer

Featuring:
Dr. Scott Berry

Best of GUGI 2017 - Hepatobiliary Cancer

Featuring:
Dr. Jennifer Knox

Best of ASCO Toronto 2017 - GI Colorectal Cancer

Featuring:
Dr. Ronald Burkes

Best of ASCO Toronto 2017 - GI Non-Colorectal Cancer

Featuring:
Dr. Mark Doherty

Best of ASCO Montreal 2017 - GI Non-Colorectal Cancer

Featuring:
Dr. Isabelle Gingras

Best of ASCO Vancouver 2017 - GI Colorectal Cancer

Featuring:
Dr. Scot Dowden

Best of ASCO Vancouver 2017 - GI Non-Colorectal Cancer

Featuring:
Dr. Sharlene Gill

Left vs Right-Sided Colorectal Tumours - Does Location of the Primary Impact Clinical Practice?

Featuring:
Dr. Marc Peeters
Dr. Rachel Goodwin, Chair

Best of Oncology West 2016 - GI Colorectal

Featuring:
Dr. Sharlene Gill

Best of Oncology West 2016 - GI Non-Colorectal

Featuring:
Dr. Christina Kim

Highlights from 2017 ASCO GI Symposium

Featuring:
Dr. Scott Berry
Dr. Daniel Renouf
Dr. Winson Cheung
Dr. Mustapha Tehfe

2016 Pancreatic Cancer Year in Review

Featuring:
Dr. Scott Berry
Dr. Daniel Renouf
Dr. Winson Cheung
Dr. Mustapha Tehfe

Best of Oncology East 2016 - GI Colorectal Cancer

Featuring:
Dr. Ronald Burkes

Best of Oncology East 2016 - GI Non-Colorectal Cancer

Featuring:
Dr. Yoo-Joung Ko

Innovative Approaches to the Management of Pancreatic Cancer

Featuring:
Dr. Philip Philip

Treatment and Management Considerations in Advanced Pancreatic Cancer

Featuring:
Dr. Philip Philip

Resectable Pancreatic Cancer and Beyond_The Role of Neoadjuvant and Adjuvant Therapies

Featuring:
Dr. Philip Philip

Emerging Evidence in Localized Disease Management

Featuring:
Dr. Philip Philip

The Future - Targeted Therapies for the Treatment of Pancreatic Adenocarcinoma

Featuring:
Dr. Philip Philip

Approaches to Pancreatic and GI NETs Using the New Canadian Guidelines (English)

Featuring:
Dr. Simron Singh
Dr. Rachel Goodwin

Approaches to Pancreatic and GI NETs Using the New Canadian Guidelines (French)

Featuring:
Dr. Simron Singh
Dr. Rachel Goodwin

Round Table Discussion: Colorectal Cancer Highlights from ESMO 2016

Featuring:
Dr. Scott Berry
Dr. Scot Dowden
Dr. Hagen Kennecke

LUME-Colon 1 Study

Featuring:
Dr. Scott Berry

GI Non-Colorectal Cancer Highlights

Featuring:
Dr. Tim Asmis

CCTG/AGITG CO.23 Trial

Featuring:
Dr. Derek Jonker

The FACS Randomized Clinical Trial

Featuring:
Dr. John Primrose

Dabrafenib, Trametinib, and Panitumumab in BRAF V600E–Mutated mCRC

Featuring:
Dr. Ryan Corcoran

NGS Identifies Distinct Molecular Signatures of HER2 Inhibition

Featuring:
Dr. Yelena Janjigian

CheckMate-040 Study

Featuring:
Dr. Ignacio Melero

GOLD Study

Featuring:
Dr. Yung Bang

Webinar Archive: ASCO 2016 Updates

Key GI Cancer Trials

Featuring:
Dr. Scott Berry

Best of ASCO Vancouver 2016 - GI Non-Colorectal Cancer

Featuring:
Dr. Sharlene Gill

Best of ASCO Vancouver 2016 - GI Colorectal Cancer

Featuring:
Dr. Scot Dowden

Circulating Tumour DNA to Reshape the Design of Clinical Trials

Featuring:
Dr. Jeanne Tie

Best of ASCO Toronto 2016 - GI Non-Colorectal Cancer

Featuring:
Dr. Rachel Goodwin

Best of ASCO Toronto 2016 - GI Colorectal Cancer

Featuring:
Dr. Ron Burkes

Best of ASCO Montreal 2016 - GI Non-Colorectal Cancer

Featuring:
Dr. Thierry Alcindor

Best of ASCO Montreal 2016 - GI Colorectal Cancer

Featuring:
Dr. Scott Berry

CALGB 80802 (NCIC HEC 1) & ESPAC-4 Updates

Featuring:
Dr. Vincent Tam

ESPAC-4 Trial

Featuring:
Dr. John Neoptolemos

NETTER-1 Study

Featuring:
Dr. Jonathan Strosberg

CREST Study

Featuring:
Dr. James Hill

Analysis of CALGB/SWOG 80405 (Alliance)

Featuring:
Dr. Alan Venook

Gastric Cancer in Ontario

Featuring:
Dr. Natalie Coburn

Systemic Therapy for Metastatic Gastric Cancer

Featuring:
Dr. Scott Berry

The Future of Stage IV Gastric Cancer Management

Featuring:
Dr. Han-Kwang Yang

Best of GUGI 2016 - Pancreatic Cancers

Featuring:
Dr. Daniel Renouf

Best of GUGI 2016 - Esophago-Gastro and Colorectal Cancer

Featuring:
Dr. Scot Dowden

Best of GUGI 2016 - Esophago-Gastro Cancer

Featuring:
Dr. Christine Brezden-Masley

Best of Oncology West 2017 - GI Non-Colorectal Cancers

Featuring:
Dr. Daniel Renouf

Best of Oncology West 2017 - GI Colorectal Cancer

Featuring:
Dr. Patricia Tang

Dinner Symposium: The Management of Metastatic Gastric Cancer

Featuring:
Dr. Sharlene Gill
Dr. Emile Woo
Dr. Howard Lim

EVOLVE: Module II: Chemotherapeutic Strategies Before & After Resection of Hepatic Metastases

Featuring:
Dr. Scot Dowden

EVOLVE: Module II: Curative-Intent Strategies in Metastatic Colorectal Cancer (mCRC)

Featuring:
Dr. Scot Dowden

EVOLVE: Module II: Conversion Strategies in Initially Unresectable mCRC Patients

Featuring:
Dr. Scot Dowden

EVOLVE: Module II: Biomarkers of Interest for Anti-EGFRs

Featuring:
Dr. Scot Dowden

EVOLVE: Module II: Targeted Therapies: Which Pathways are Involved in Their Mechanism of Action?

Featuring:
Dr. Scot Dowden

EVOLVE: Module II: The Role of Biomarkers in the Management of Metastatic Colorectal Cancer (mCRC)

Featuring:
Dr. Scot Dowden

EVOLVE: Module II: The Role of Targeted Agents in Initially Unresectable mCRC Patients

Featuring:
Dr. Scot Dowden

EVOLVE: Module I: Intermittent Chemotherapy

Featuring:
Dr. Scott Berry

EVOLVE: Module I: Sequential Therapy

Featuring:
Dr. Scott Berry

EVOLVE: Module I: What are the Options for Chemorefractory mCRC?

Featuring:
Dr. Scott Berry

EVOLVE: Module I: What Strategies Help to Minimize the Toxicities of mCRC Treatment?

Featuring:
Dr. Scott Berry

EVOLVE: Module I: Pallative First-Line Therapy in mCRC: What Role Can Biologics Play?

Featuring:
Dr. Scott Berry

EVOLVE: Module I: Pallative-Intent Strategies in the Management of Metastatic Colorectal Cancer

Featuring:
Dr. Scott Berry

EVOLVE: Module I:Pallative First-Line Therapy in mCRC: Comparing Biologics

Featuring:
Dr. Scott Berry

EVOLVE: Module I: Pallative Second-Line Therapy in mCRC: Continuation of a Biologic After First-Line Progression

Featuring:
Dr. Scott Berry

EVOLVE: Module I:Pallative First-Line Therapy in mCRC: Comparing BiologicsPallative Second-Line Therapy in mCRC: What Role Can Biologics Play?

Featuring: Dr. Scott Berry

Webinar Archive: Advanced Pancreatic Cancer: Current Clinical Options and Future Directions

Featuring:
Dr. Malcolm Moore
Dr. Hedy Kindler
Dr. Scott Berry

Webinar Archive: Navigating Later Lines of Treatment for Advanced Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Bruce Colwell
Dr. Scot Dowden
Dr. Sharlene Gill

Webinar Archive: A Case-Based Approach to Hepatocellular Carcinoma

Featuring:
Dr. Ravi Ramjeesingh

Innovative Approaches to the Management of Pancreatic Cancer

Featuring:
Dr. Philip Philip

BRAF Inhibitors in Colorectal Cancer - ENA 2014

Featuring:
Dr. Philippe Bedard

EVOLVE: Module I: What are the Options for Chemorefractory mCRC?

Featuring:
Dr. Scott Berry

ASCO20 Virtual Data Watch: GI Cancers

Does treatment sequencing matter in metastatic colorectal cancer?

Featuring:
Dr. Julien Taieb
Chair:
Dr. Scott Berry

Foxtrot Study

Featuring:
Dr. Dion Morton

KEYNOTE-181 study

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

Colorectal Cancer

Featuring:
Dr. Ron Burkes

GI Colorectal

Featuring:
Dr. Patricia Tang

ESMO 2020 Virtual Data Watch - GI

GI Colorectal and Non-Colorectal

Featuring:
Dr. Sharlene Gill

KEYNOTE-177 & PANDA

Metastatic Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Understanding the Approach to Managing Skin Toxicities Associated with Managing mCRC

Featuring:
Dr. Mario Lacouture
Chair:
Dr. Nathan Lamond

CheckMate 649, ATTRACTION-4, KEYNOTE-062, KEYNOTE-590 and CheckMate 577

Gastroesophageal Cancer
Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

GI Non-Colorectal

Featuring:
Dr. Sharlene Gill

Polo Trial

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

NRG-GI002 Study

Featuring:
Dr. Thomas George

Colorectal GI Cancer

Featuring:
Dr. Mark Doherty

Atezo + Bev in HCC

Featuring:
Dr Michael Pishvaian

KEYNOTE-177 Study

Featuring:
Dr. Thierry André

Colorectal and Non Colorectal GI Cancer

Featuring:
Dr. Benoit Samson

The COMPASS Trial

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

MEDETREME Trial

Featuring:
Dr. Francois Ghiringhelli

GI Colorectal and Non-Colorectal Cancer Update

Featuring:
Dr. Mike Vickers

Best of Oncology East 2018 - Colorectal GI Cancer

Featuring:
Dr. Scott Berry